FDA Finds Violations At Pa. J&J Plant

Law360, New York (July 19, 2010, 5:31 PM EDT) -- The U.S. Food and Drug Administration has given Johnson & Johnson's medicinal joint venture with Merck & Co. a warning about potential problems at a manufacturing plant the company operates in Lancaster, Pa.

Johnson & Johnson/ Merck Consumer Pharmaceuticals Co. received a Form 483 report from the FDA following the agency’s recent inspection of the Lancaster manufacturing facility, the company said Monday.

A Form 483 report details any problems found during an FDA inspection.

“JJ/MCP takes the issues raised by the agency seriously and is fully...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.